# Are risk minimization measures for approved drugs in Europe effective? A systematic review

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/are-risk-minimization-measures-for-approved-drugs-in-europe-effective-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Esther Artime,Nawab Qizilbash,Macarena Garrido‐Estepa,Pareen Vora,Montse Soriano‐Gabarró,Alex Asiimwe,Stuart Pocock |
| Citations | 36 |
| DOI | 10.1080/14740338.2019.1612875 |
| Fields | Economics, Econometrics and Finance,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2942464288 |
| PMID | 31032651 |
| Type | review |
| Year | 2019 |

## Paper authors

- [Esther Artime](https://scholariq.org/researchers/esther-artime/)

## Paper journal

- [Expert Opinion on Drug Safety](https://scholariq.org/journals/expert-opinion-on-drug-safety/)

## Paper primary topic

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Paper topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.